Board of Directors

ICCBBA is governed by a volunteer Board of Directors comprised of leading experts in blood transfusion, cellular therapy, and tissue transplantation from around the world. Board positions are advertised publicly and Board members normally serve six-year terms. The current Board of Directors has members from Australia, Bhutan, China, the Netherlands, Saudi Arabia, Singapore, the United Kingdom, and the United States.

ICCBBA Board of Directors


 Diana Teo (Chairman)

Ruth Warwick (Vice-Chairman)

Salwa Hindawi (Secretary)

Celso Bianco (Treasurer)

Jeremy Chapman

Mahrukh Getshen

Che-Kit Lin

Ineke Slaper-Cortenbach

Diane Wilson




Diana Teo, MD


Diana TeoDiana Teo graduated from National University of Singapore in 1982 with an M.B.,B.S. degree. Obtained Master of Science degree in Medical Immunology from the University of London, followed by Membership of the Royal College of Pathologists, UK in 1993, and Fellowship of the Royal College of Pathologists in 2001. Accredited by the UK General Medical Council Specialist  Register in the Speciality of Immunology, and Certificate of Specialist Accreditation, Ministry of Health, Singapore in the Speciality of Pathology. Awarded the Singapore National Day Honours Public Administration Medal  (Silver) in 2008.


Appointed Director, Centre for Transfusion Medicine, Health Sciences Authority (HSA) since January 2003, and the Group Director, Blood Services Group, HSA since August 2008. Chairman of the HSA Professional Board since January 2009. The Blood Services Group is the national blood service in Singapore, and is AABB accredited in blood banking and transfusion medicine and ASHI accredited in tissue typing. The Blood Services Group is also a WHO Collaborating Centre for Transfusion Medicine. Other relevant appointments include the Ministry of Health Specialist Training Committee for Haematology, President of the Singapore Society of Haematology from 2002 to 2004, Member of the Board of Directors (Asia-Pacific Region Director) for International Society of Blood Transfusion, Vice Chair of the Asia Pacific Blood Network, Member of the WHO Expert Advisory Panel for Transfusion Medicine, and Member of the Board of Directors for ICCBBA.  


Dr Teo's main interests within Transfusion Medicine include: organizational and quality systems in blood transfusion services, blood safety, and global development in transfusion medicine.



Ruth M Warwick MB, ChB


Ruth WarwickRuth Warwick qualified in Medicine from Bristol University UK (1973) and specialized in clinical haematology (Royal Free, Hillingdon & Hammersmith Hospitals). She worked in Transfusion Medicine and as Consultant Specialist for Tissue Services for the National Health Service Blood & Transplant (NHSBT) from 1993 to 2010. She is a Fellow of the Royal College of Physicians MRCP 1977, FRCP 1997, & Fellow of the Royal College of Pathologists MRCPath 1980, FRCPath 1992. She is a past President of the European Association of Tissue Banks (2007-2009) and a past President of British Association for Tissue Banking (2006-2008). She was Chairman of the EC CEN ISSS Workshop on Coding & Traceability of Tissues & Cells (2007-2008). She has had national & international experience in policy setting; the founder Chair of the National Institute for Biological Standards & Controls /UK Blood Services Tissues Advisory Committee for Tissues and Haemopoietic Stem Cells (1995-2001), Consultant for the Council of Europe Expert Group on Organs Tissues & Cells (1999-2001) and its editing group for the first Guide for the Quality and Safety of Tissues and Cells 2012 & advisory roles for the English Department of Health Transplant Policy Unit & Human Tissue Authority.


She has over 120 published papers, edited volumes including lead editor of two multinational books in Tissue and Cell Donation and Usage (published 2009 and 2012), chapters, and letters and over 110 abstracts. She has been a member of the Board of Directors since 2010. 



Salwa Hindawi

 Saudi Arabia


Salwa Hindawi qualified in medicine at the King Abdulaziz University Medical School, Jeddah, Saudi Arabia (1985) and specialised in Haematology at the Hammersmith Hospital, London. She is a Fellow of the Royal College of Pathologists (MRCPath 1999; FRCPath 2007). Dr Hindawi is Medical Director of Blood Transfusion Services and Associate Professor in Haematology and Transfusion Medicine at the King Abdulaziz Hospital, Jeddah. She is President of the Saudi Society of Transfusion Medicine and a Member of the Saudi National Advisory Committee for Transfusion Medicine and Stem Cells. She is a member of the World Health Organization Expert Advisory Panel for Blood Transfusion and the WHO Expert Committee for Biological Standardization.

Dr Hindawi has many publications including co-authorship of “Introduction to Blood Banking and Transfusion Medicine” (2011) and a contributing a chapter to “Haemovigilance: An Effective Tool for Improving Transfusion Safety” (2012, Editors: De Vries and Faber).



Celso Bianco, MD


BiancoDr. Bianco grew up in São Paulo, Brazil and received his medical degree from the Medical School of São Paulo. He was assistant professor of pathology at the New York University School of Medicine and at Rockefeller University in New York. He then joined the State University of New York in Brooklyn, N.Y., where he became Professor of Pathology. He joined the New York Blood Center as Director of Science and Technology in 1982 and in 1992 became the Vice President, Medical Affairs. In 2000, he became America’s Blood Centers Executive Vice President from where he retired in September 2012.


He published many papers in immunology and on diseases transmissible by transfusion. He was a member of the U.S. Advisory Committee on Blood Safety and Availability, the New York State Council on Blood and Transfusion Services and the Industry Representative of the U.S. FDA Blood Products Advisory Committee. He is a member of AABB and its Transfusion Transmitted Diseases Committee, the American Society of Hematology and the International Society of Blood Transfusion (ISBT) Working Party on Transfusion Transmitted Infectious Diseases. He became president-elect of ISBT in July 2012 and will assume the presidency in June 2014.  


Jeremy Chapman, MD


Jeremy ChapmanProfessor Jeremy Chapman is a renal physician with a special interest in transplantation. He is Director of Renal Medicine at Westmead Hospital, Consultant to the NSW Australian Red Cross Blood Service Tissue Typing Laboratory and Chairman of the Australian Bone Marrow Donor Registry, the Australian Cord Blood Bank Network and Past President of the Transplantation Society of Australia and New Zealand. He is a member of the Advisory Council of the Australian Organ and Tissue Authority.


He is the Past-President of The Transplantation Society, Advisory Member of The World Health Organisation Expert Advisory Panel on Human Cell Tissue and Organ Transplantation, Secretary General and Past President of the World Marrow Donor Association and CoChair of the Declaration of Istanbul Custodian Group. He received the Asturias Foundation 2010 Award for International Cooperation on behalf of The Transplantation Society. He was awarded the 2010 David Hume Award of the US National Kidney Foundation.


Professor Chapman's clinical work is in renal medicine, transplantation of kidney and pancreas and diabetic renal disease and islet transplantation.


Professor Chapman is actively involved in the academic field having over 320 publications. He is a Clinical Professor at the University of Sydney, a Fellow of the Royal College of Physicians in the United Kingdom and Fellow of the Royal Australasian College of Physicians.  

Mahrukh Getshen


Getshen Mahrukh Getshen graduated from Grant Medical College, Bombay University, India in 1987 with a MBBS degree. She obtained a diploma in Blood Banking and Transfusion Medicine from Mahidol University, Bangkok, Thailand in 2002; and a Master of Public Health from Queensland University of Technology, Brisbane, Australia in 2012.


She has been heading the National Blood Bank at JDW, National Referral Hospital located in Thimphu, Bhutan since 2002. Being the first and only specialist in the field of Transfusion Medicine, her responsibilities include providing technical expertise and policy guidance to the National Blood Safety Program under the Ministry of Health, Royal Government of Bhutan.


She has been actively involved in the promotion of Voluntary Non-remunerated Blood Donation activities in the capital and nationwide, and her efforts have helped increase the percentage of VNRBD from 30% in 2002, to 90% in 2014 at the National Blood Bank. Her contribution includes creation of the National Blood Policy, Bhutan; Standards and National Guidelines and National Assessment Schemes in Immuno-hematology.


Mahrukh Getshen has been a member of the World Health Organization Expert Advisory Panel for Blood Transfusion since 2010, and is one of the current Vice-Presidents of the Asian Association of Transfusion Medicine (AATM). She is the recipient of the ISBT Runner-Up Award (Individual Category) for Developing Countries, July 2012. She is also an advocate of the rights and dignity of persons with diverse abilities, and dedicates her free time and services as a member on the Board of Trustees of Ability Bhutan Society, a civil society organization under the Patronage of Her Majesty, the Queen of Bhutan.  


Dr. Che-Kit Lin, MBBS, FRCPA, FHKAM(Path)

 Hong Kong SAR, China

Che Kit LINAfter graduating from the University of Hong Kong with an M.B., B.S. degree, Dr Che-Kit LIN was trained in laboratory haematology and has obtained Fellowship of the Royal College of Pathologists, Australasia, the Hong Kong Academy of Medicine (Pathology), the Hong Kong College of Pathologists and the Hong Kong College of Community Medicine, and Master in Business Administration in University of Birmingham, UK.


Dr LIN joined the Hong Kong Red Cross Blood Transfusion Service (HKRCBTS) in 1990 and has been its Chief Executive and Medical Director since 1995. In addition to the territory-wide blood programme, the HKRCBTS is also responsible for the unrelated haematopoietic stem cell programme in Hong Kong. He is also the honorary Clinical Associate Professor, Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong. In addition to many local professional bodies and government committees, he is also actively involved in many international blood transfusion related bodies and is currently the Chairman of the Asia-Pacific Blood Network and the Asian-Pacific Zonal Coordinator, Global Advisory Panel on Corporate Governance and Risk Management for Blood Services in Red Cross Societies, International Federation of Red Cross and Red Crescent Societies, council member of the Chinese Society of Blood Transfusion, honorary consultant of the Shanghai Blood Centre and member of the WHO Expert Advisory Panel for Transfusion Medicine.


Dr LIN's interests within Transfusion Medicine are mainly voluntary non-remunerated blood donation, donor and blood safety.


Dr. Ineke Slaper-Cortenbach, PhD

 The Netherlands

Ineke_BoDDr. Ineke Slaper-Cortenbach is currently the head of the Cell Therapy Facility (CTF) in the UMC Utrecht with 30 years' experience as a laboratory director of cell therapy. She is an internationally well-known leading authority in regulatory affairs of cellular products. She has been a member of Board of Directors of ICCBBAA (2006 – 2013). At the moment, she is member of the CTCLAG, Chair of the Tissue Engineering Products Technical Advisory Group (TEPTAG) and member of the Standards Committee of ICCBBA.


Her expertise is also reflected by taking lead in multiple national and international organizations: i.e. (past) presidency for JACIE, several positions within ISCT (i.e. for 7 years she was the chair of the European LRA Committee), Expert on the Working Party on Cell Therapeutic Products of the European Pharmacopeia Committee and chair of the Dutch Expert Group on ATMPs. She is a member of of the Cell Therapy & Immunobiology Working Party (CTIWP) of the EBMT.


The CTF was the first academic hospital to achieve GMP-accreditation in the Netherlands and has a license for the production of all ATMP classes not only for national but also for international partners. Her main interest in research is the development of GMP-approved manufacturing procedures for ATMPs. Examples are Mesenchymal Stromal Cells, which are currently manufactured animal-protein free using platelet lysate for multiple trials.


Diane Wilson, BSN, MSN/MHA


Wilson_BoDDiane Wilson is the Chief Operating Officer of Community Tissue Services. Diane has more than 30 years of experience in Tissue Banking. She has held numerous positions in the American Association of Tissue Banks “AATB” (Board of Governors, Chair of the Standards Committee, Accreditation Inspector, Chair of the Membership Committee, and Chair of the Tissue Bank Council). She is a past President for AATB. She also served as a Member of the Committee for the Coalition on Donation of AATB and as a Member of AABB. She has been an educator for the AATB Certified Tissue Bank Specialist Training Course for the past 25 years. She is a Member of AATB, the National Association of Orthopedic Nurses, and the Association of peri-Operating Room Nurses.


Diane Wilson is currently a board member of ICCBBA, the Chair of the North American Tissue Banking Technical Advisory Group (NATTAG), a member of the Tissue Engineered Products Technical Advisory Group (TEPTAG), a Medical Advisory and Policy Board Member of the Gift of Life Donor Program, and is the Chairman of the Board for Joint Restoration Foundation, Inc. She is a Registered Nurse and holds an Associate of Science in Nursing degree from Everett Community College, a Bachelor of Science in Nursing degree from the University of Phoenix, and a Master’s Degree in Nursing and Health Administration from the University of Phoenix.


[Last Modified: 21 May 2015] 


[Back to Top ↑]